Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza

Vaccine

Volumn 28, Issue 27, 2010, Pages 4430-4437

  Liljebjelke, Karen A ^a   Petkov, Daniel I ^a   Kapczynski, Darrell R ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Attenuated Salmonella; Influenza A virus; Poultry; Vaccine

Indexed keywords

AVIAN INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVIAN INFLUENZA; CHICKEN; CODON; CONTROLLED STUDY; DRUG EFFICACY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; IMMUNIZATION; INFLUENZA A (H5N1); INFLUENZA VACCINATION; MALE; MUCOSAL IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTECTION; SALMONELLA TYPHIMURIUM; SURVIVAL RATE;

ANIMALS; CHICKENS; HEMAGGLUTININS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; SALMONELLA;

EID: 77952744639     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.009     Document Type: Article

References (29)

1. Skehel J.J., and Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69 (2000) 531-569
2. Ada G.L., and Jones P.D. The immune resonse to influenza infection. Curr Top Microbiol Immunol 128 (1986) 1-54
3. Swayne D.E., Garcia M., Beck J.R., Kinney N., and Suarez D.L. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine cotaining an H5 avian influenza hemagglutinin gene insert. Vaccine 18 (2000) 1088-1095
4. Swayne D.E., and Kapczynski D.R. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev 225 (2008) 314-331
5. Robinson H.L., Hunt L.A., and Webster R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11 (1993) 957-960
6. Webster R.G., Kawaoka Y., Taylor J., Weinberg R., and Paoletti E. Efficacy of nucleoprotein and haemagglutinin antigens expressd in flowlpox virus as a vaccine for influenza in chickens. Vaccine 9 (1991) 3003-3008
7. Roberts M., Li J., Bacon A., and Chatfield S. Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters. Infect Immun 66 7 (1998) 3080-3087
8. Huang Y., Hajishengallis G., and Michalek S.M. Construction and characterization of a Salmonella enterica serovoar typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoter. Infect Immun 68 3 (2000) 1549-1556
9. Du A., and Wang S. Efficacy of a DNA vaccine delivered in attenuated Salmonella typhimurium against Eimeria tenella infection in chickens. Int J Parasitol 35 7 (2005) 777-785
10. Vecino W.H., Quanquin N.M., Martinez-Sobrido L., Fernandez-Sesma A., Garcia-Sastre A., Jacobs W.R., et al. Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge. Virology 325 (2004) 192-199
11. Sirard J.C., Neirdergang F., and Kraehenbuhl J.P. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol Rev 171 (1999) 5-26
12. Chatfield S.N., Charles I.G., Makoff A.J., Oxer M.D., Dougan G., Pickard D., et al. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology 10 8 (1992) 888-892
13. Chatfield S.N., Strahan K., Pickard D., Charles I.G., Hormaeche C.E., and Dougan G. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb Pathol 12 2 (1992) 145-151
14. Dunstan S.J., Simmons C.P., and Strugnell R.A. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen. Infect Immunol 66 2 (1998) 732-740
15. Hoiseth S.K., and Stocker B. A aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291 5812 (1981) 238-239
16. Methner U., Barrow P.A., Martin G., and Meyer G.H. Comparative study of the protective effect against Salmonella colonization in newly hatched SPF chickens using live, attenuated Salmonella vaccine strains, wild-type Salmonella strains or a competitive exclusion product. Int J Food Microbiol 35 3 (1997) 223-230
17. Betancor L., Schelotto F., Fernandez M., Pereira M., Rial A., and Chabalgoity J.A. An attenuated Salmonella enteritidis strain derivative of the main genotype circulating in Uruguay is an effective vaccine for chickens. Vet Microbiol 107 1-2 (2005) 81-89
18. Roland K., Karaca K., and Sizemore D. Expression of Escherichia coli antigens in Salmonella typhimurium as a vaccine to prevent airsacculitis in chickens. Avian Dis 48 3 (2004) 595-605
19. + for all three chromosomally located systems of DNA restriction and modification. J Bacteriol 156 1 (1983) 471-474
20. Pogonka T., Klotz C., Kovacs F., and Lucius R. A single dose of recombinant Salmonella typhimurium induces specific humoral immune responses against heterologous Eimeria tenella antigens in chicken. Int J Parasitol 33 1 (2003) 81-88
21. Dunstan S.J., Simmons C.P., and Strugnell R.A. Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. typhimurium. Infect Immunol 67 10 (1998) 5133-5141
22. Oxer M.D., Bentley C.M., Doyle J.G., Peakman T.C., Charles I.G., and Makoff A.J. High level heterologous expression in E. coli using the anaerobically-activated nirB promoter. Nucl Acids Res 19 11 (1991) 2889-2892
23. Swayne DE, Senne DA, Beard CW. Avian influenza. In: Swayne DE, editor. A laboratory manual for the isolation and identification of avian pathogens, 4th ed. Kennett Square: American Association of Avian Pathologists; 1996. p. 150-5.
24. Strugnell R., Dougan G., Chatfield S., Charles I., Fairweather N., Tite J., et al. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P69 antigen of Bordetella pertussis. Infect Immunol 60 10 (1992) 3994-4002
25. Nishimura A., Morita M., Nishimura Y., and Sugino Y. A rapid and highly efficient method for preparation of competent Escherichia coli cells. Nucl Acids Res 18 20 (1990) 6169-6170
26. Holt P.S., Vaughn L.E., Gast R.K., and Stone H.D. Development of a crop lavage procedure to collect crop secretions from live chickens for studying crop immunity. Avian Pathol 6 (2002) 589-592
27. Klenk H.D., Wagner R., Heuer D., and Wolff T. Importance of hemagglutinin glysosylation for the biological functions of influenza virus. Virus Res 82 (2002) 73-75
28. Pan Z., Zhang X., Geng S., Cheng N., Sun L., Liu B., et al. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus. Vaccine 27 7 (2009) 1018-1023
29. Swayne D.E., Lee C.W., and Spackman E. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathol 35 2 (2006) 141-146